UGONE, VALERIA
 Distribuzione geografica
Continente #
AS - Asia 1.035
NA - Nord America 758
EU - Europa 431
SA - Sud America 220
AF - Africa 31
OC - Oceania 1
Totale 2.476
Nazione #
US - Stati Uniti d'America 709
SG - Singapore 465
CN - Cina 196
IT - Italia 195
BR - Brasile 171
HK - Hong Kong 127
VN - Vietnam 120
FR - Francia 69
NL - Olanda 37
BD - Bangladesh 33
AR - Argentina 22
CA - Canada 21
GB - Regno Unito 20
FI - Finlandia 18
MX - Messico 17
DE - Germania 15
IN - India 15
KR - Corea 14
EC - Ecuador 12
ID - Indonesia 11
AT - Austria 10
IE - Irlanda 10
JP - Giappone 9
SE - Svezia 9
ES - Italia 8
TR - Turchia 7
ZA - Sudafrica 7
UA - Ucraina 6
IQ - Iraq 5
MA - Marocco 5
PL - Polonia 5
PT - Portogallo 5
RO - Romania 5
CO - Colombia 4
LT - Lituania 4
PY - Paraguay 4
SA - Arabia Saudita 4
CL - Cile 3
DZ - Algeria 3
JM - Giamaica 3
KZ - Kazakistan 3
NG - Nigeria 3
PK - Pakistan 3
RU - Federazione Russa 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
BF - Burkina Faso 2
BG - Bulgaria 2
BO - Bolivia 2
CG - Congo 2
CY - Cipro 2
EG - Egitto 2
GR - Grecia 2
IL - Israele 2
OM - Oman 2
SN - Senegal 2
TH - Thailandia 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
YT - Mayotte 1
Totale 2.476
Città #
Singapore 253
Santa Clara 221
Hong Kong 126
Ashburn 60
San Jose 56
Beijing 47
Los Angeles 47
Lauterbourg 46
Ho Chi Minh City 43
Hanoi 36
Milan 30
Hefei 28
São Paulo 27
Sala Baganza 26
Amsterdam 24
Dallas 18
Guangzhou 17
Cavallino 16
New York 16
Genoa 14
Lappeenranta 14
Seoul 13
Orem 11
Cagliari 10
Vienna 10
Denver 9
Bitonto 8
Dublin 8
Frankfurt am Main 8
Stockholm 8
Boston 7
Buffalo 7
Naples 7
Phoenix 7
Quito 7
Turin 7
Boardman 6
Houston 6
Poplar 6
Rome 6
Tokyo 6
Afragola 5
Bologna 5
Brasília 5
Brooklyn 5
Da Nang 5
Dhaka 5
Florence 5
Montreal 5
Querétaro 5
Betim 4
Bucharest 4
Haiphong 4
Johannesburg 4
London 4
Warsaw 4
Ananindeua 3
Belo Horizonte 3
Biên Hòa 3
Campinas 3
Chennai 3
Düsseldorf 3
Florianópolis 3
Palermo 3
Paris 3
Portsmouth 3
Pueblo 3
Rio de Janeiro 3
Tempio Pausania 3
Trieste 3
Almaty 2
Antakya 2
Arapiraca 2
Atlanta 2
Baku 2
Blumenau 2
Brazzaville 2
Bridgetown 2
Bình Dương 2
Bình Dương Province 2
Cairo 2
Camaragibe 2
Can Tho 2
Cape Town 2
Caxias do Sul 2
Charlotte 2
Chicago 2
City of London 2
Council Bluffs 2
Curitiba 2
Dakar 2
Dores do Rio Preto 2
Dubai 2
Grand Rapids 2
Guayaquil 2
Helsinki 2
Ibadan 2
Irecê 2
Istanbul 2
Jakarta 2
Totale 1.493
Nome #
Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes 95
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 87
Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins 71
Mo(VI) Potential Metallodrugs: Explaining the Transport and Cytotoxicity by Chemical Transformations 70
Antioxidant Properties and Radical Production Capability of the Potential Antitumor V(IV)O Complexes Formed by Flavonoid Ligands 68
Vanadium-proteins. Structure, binding, characterization and biological implications 67
Covalent and non-covalent binding in vanadium-protein adducts 66
Spectroscopic/Computational Characterization and the X-ray Structure of the Adduct of the VIVO-Picolinato Complex with RNase A 62
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins 61
Thermodynamic study of oxidovanadium(Iv) with kojic acid derivatives: A multi-technique approach 61
A Study on the Photoisomerization of (E)-Dehydrozingerone, Its (E)-(E)-C₂ Symmetric Dimer, and Their O-Methylated Derivatives 60
Speciation and biorelevant reactions of the potential anti-tumor agent vanadocene dichloride 59
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug. 56
Influence of temperature on the equilibria of oxidovanadium(iv) complexes in solution 54
Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes 53
Nonoxido V(IV) complexes: Prediction of the EPR spectrum and electronic structure of simple coordination compounds and amavadin 50
Interaction of the potent antitumoral compounds Casiopeinas® with blood serum and cellular bioligands 49
In-Depth Mass Spectrometry Study of Vanadium(IV) Complexes with Model Peptides 49
Interaction of vanadium(IV,V) coordination complexes with proteins 49
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 3. Antioxidant properties and radical production capability 48
Biotransformation of oxidovanadium(IV) complexes with oxydiacetate and NN-heterocycles 48
Speciation of the Potential Antitumor Agent Vanadocene Dichloride in the Blood Plasma and Model Systems 45
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies 45
Biotransformation in the blood serum of potential antitumor V(IV)O2+ complexes and interaction with red blood cells 45
Speciation of vanadocene dichloride in the blood plasma 44
Interaction of pharmacologically active pyrone and pyridinone vanadium(IV,V) complexes with cytochrome c 44
Interaction of vanadocene dichloride with the blood serum components 43
Characterization of oxidovanadium(IV) complexes with quinolones 42
Novel porphyrin-containing hydrogels obtained by frontal polymerization: Synthesis, characterization and optical properties 42
Characterization and biotransformation in the plasma and red blood cells of VIVO2+ complexes formed by ceftriaxone 41
Interaction of V(V) complexes formed by picolinic and pyrazinecarboxylic acid derivatives with red blood cells 40
Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride 38
Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin 38
Integrated instrumental/computational methods to characterize the binding to proteins and biospeciation of potential vanadium drugs 37
Interaction of vanadium compounds with Cytochrome c 37
Equilibrium between Different Coordination Geometries in Oxidovanadium(IV) Complexes. 37
Interaction of potential vanadium drugs with proteins studied by an experimental and computational approach 36
Speciation of potential anti-diabetic vanadium complexes in real serum samples 36
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 1. Coordination modes and geometry in solution and at the physiological pH. 36
Integrated ESI-MS/EPR/computational characterization of the binding of metal species to proteins: vanadium drug-myoglobin application 35
Biotransformation in the blood serum of potential antitumor V(IV)O2+ complexes and interaction with red blood cells 35
Interaction of Vanadium(IV) Species with Ubiquitin: A Combined Instrumental and Computational Approach 34
Binding of potential antitumor Casiopeínas® to small proteins 33
Characterization of the coordination modes of flavonoids towards oxidovanadium(IV) 33
VO complexes with antibacterial quinolone ligands and their interaction with serum proteins. 31
Evaluation of antifungal and antimycotoxigenic activity of selected natural antioxidants against Fusarium culmorum: in vitro and in planta assays 31
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction 30
Integrative spectroscopic-docking methods for the study of the interaction between vanadium complexes and proteins 29
Decoding Surface Interaction of V(IV)O Metallodrug Candidates with Lysozyme 28
Chemistry of oxidomolybdenum(IV) and -(VI) complexes with ONS donor ligands: Synthesis, computational evaluation and oxo-transfer reactions 28
Speciation in aqueous solution and interaction with low and high molecular mass blood bioligands of [VIVO(oda)(H2O)2], a V compound with in vitro anticancer activity 27
Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations. 27
V(IV)O and V(IV) Species Formed in Aqueous Solution by the Tridentate Glutaroimide-Dioxime Ligand - An Instrumental and Computational Characterization 27
Temperature and Solvent Structure Dependence of VO2+ Complexes of Pyridine-N-oxide Derivatives 24
Synthesis, crystal structures, EPR and DFT studies of first row transition metal complexes of lignin model compound ethylvanillin 24
Complex formation between [(eta(6)-p-cym)Ru(H2O)(3)](2+) and oligopeptides containing three histidyl moieties 22
Effect of secondary interactions, steric hindrance and electric charge on the interaction of V(IV)O species with proteins 21
Estratto fenolico di bacche di mirto comune e composizione farmaceutica orale contenente il suddetto estratto in combinazione con un complesso di vanadio 14
Totale 2.542
Categoria #
all - tutte 8.584
article - articoli 6.334
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202458 0 0 0 0 0 0 0 0 26 9 15 8
2024/2025949 110 5 77 29 158 60 8 54 65 40 198 145
2025/20261.481 42 79 102 250 322 112 185 86 85 99 58 61
2026/202754 54 0 0 0 0 0 0 0 0 0 0 0
Totale 2.542